The new patent covers Neurosense's formulation of PrimeC, a fixed-dose combo of an approved antibiotic and anti-inflammatory.
ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...
The Mayo Clinic was awarded $12 million to support a study that will give ALS patients access to the investigational therapy ...
A $500,000 MDA research grant to a Mass General investigator will support the HEALEY ALS platform trial that's testing ...
Columnist Juliet Taylor chats with Roon CEO and co-founder Vikram Bhaskaran about this new ALS app designed for patients and ...
Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...
Bionews, Inc., the parent company of this site, has partnered with the following nonprofit advocacy organizations to help further the mission of ensuring that patients and caregivers are able to get ...
Kristin Neva is an author, mother of two, and caregiver for her husband, Todd, who was diagnosed with ALS in 2010 when he was 39 years old. Knowing they would need family support, they moved to Upper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback